Stock 6564 ENIMMUNE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Enimmune corporation

Equities

6564

TW0006564008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
40.2 TWD -0.25% Intraday chart for Enimmune corporation +3.08% +7.20%
Mar. 13 Enimmune corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Enimmune corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Biotechnology
100.0 %
188 100.0 % 43 100.0 % -76.92%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
187 99.5 % 43 100.0 % -76.80%

Managers

Managers TitleAgeSince
Che Wei Chang CEO
 Chief Executive Officer - 17-06-07
Chung Cheng Liu CHM
 Chairman - 14-01-01
Ching Fen Yang CTO
 Chief Tech/Sci/R&D Officer - 14-07-20
Hung Tun Chen AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Chung Chi Li BRD
 Director/Board Member - 20-06-16
Che Wei Chang CEO
 Chief Executive Officer - 17-06-07
Chung Cheng Liu CHM
 Chairman - 14-01-01
Fei Pan BRD
 Director/Board Member - 14-01-01
Ching Fen Yang CTO
 Chief Tech/Sci/R&D Officer - 14-07-20
Chin Yi Chiu BRD
 Director/Board Member - 15-05-18
Chien Jun Chen BRD
 Director/Board Member - 19-01-06
Mei ling Hsiao BRD
 Director/Board Member - 20-06-16
Ta Wei Ma BRD
 Director/Board Member - 20-06-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 72,050,000 20,715,200 ( 28.75 %) 0 28.75 %

Company contact information

Enimmune Corp.

18F-2, No. 76, Section 2 Dunhua South Road

106485, Taipei

+

http://www.enimmune.com.tw
address Enimmune corporation(6564)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ENIMMUNE CORPORATION Stock Enimmune corporation
+7.20% 81.31M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.12% 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+25.25% 119B
ARGENX SE Stock argenx SE
+25.56% 27.95B
BIONTECH SE Stock BioNTech SE
-19.51% 20.5B
GENMAB A/S Stock Genmab A/S
-14.36% 17.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.63% 16.1B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-46.67% 14.97B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+11.89% 14.84B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+57.74% 14.38B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6564 Stock
  4. Company Enimmune corporation